Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
The primary objective of this study is to demonstrate the non-inferiority of the vaccine seroresponse to meningococcal serogroups A, C, Y, and W following administration of 2 doses of MenACYW conjugate vaccine compared to 2 doses of MENVEO® when given concomitantly with routine pediatric vaccines to infants and toddlers 6 to 7 months of age and 12 to 13 months of age. The secondary objectives of the study are: To demonstrate the non-inferiority of the percentage of participants with antibody t... Read More
Between 6 months and 19 months
Trial Updated:
Locations: Snake River Research, PLLC-Site Number:8400058, Idaho Falls, Idaho
Conditions: Healthy Volunteers (Meningococcal Infection)